Analyst Ratings for UroGen Pharma (URGN)
URGN Rating Summary
URGN Price Target Summary
- Highest: $50.00 (Oppenheimer)
- Lowest: $30.00 (D. Boral Capital)
- Average: $38.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$38.88 (-3.4%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 81%
Avg. $ Target:
$38.88 (-3.4%)
* Over Last 12-Mos
Rating Score: 7.7 / 10
Percentile Rank: 81%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/11/2026 | Ladenburg Thalmann | Kevin DeGeeter | New Coverage | Buy (N/A) |
43.00 (N/A) |
29.40 (40.23) |
36.84% | Details |
| 4/9/2026 | Jefferies | Amin Makarem | New Coverage | Buy (N/A) |
40.00 (N/A) |
19.10 (40.23) |
110.63% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
